Phase I/IIA randomized study of PHY906, a novel herbal agent, as a modulator of chemotherapy in patients with advanced colorectal cancer

Michael P. Farrell, Shivaani Kummar

Research output: Contribution to journalArticlepeer-review

52 Scopus citations
Original languageEnglish (US)
Pages (from-to)253-256
Number of pages4
JournalClinical Colorectal Cancer
Issue number4
StatePublished - Feb 2003
Externally publishedYes


  • 5-fluorouracil
  • Combination therapy
  • Complementary medicine
  • Herbal medicine
  • Irinotecan
  • Toxicity

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this